304 related articles for article (PubMed ID: 19684011)
21. Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis.
Khadka J; Pesudovs K; McAlinden C; Vogel M; Kernt M; Hirneiss C
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6971-7. PubMed ID: 21810983
[TBL] [Abstract][Full Text] [Related]
22. The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis.
Pesudovs K; Garamendi E; Keeves JP; Elliott DB
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2892-9. PubMed ID: 12824228
[TBL] [Abstract][Full Text] [Related]
23. Dynamic measures of visual function and their relationship to self-report of visual functioning.
Freeman EE; Muñoz B; Turano KA; West SK
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4762-6. PubMed ID: 17065485
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste.
du Toit R; Palagyi A; Ramke J; Brian G; Lamoureux EL
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996
[TBL] [Abstract][Full Text] [Related]
25. Item banking: a generational change in patient-reported outcome measurement.
Pesudovs K
Optom Vis Sci; 2010 Apr; 87(4):285-93. PubMed ID: 20142792
[TBL] [Abstract][Full Text] [Related]
26. Impact of cataract surgery on self-reported visual difficulties: comparison with a no-surgery reference group.
McGwin G; Scilley K; Brown J; Owsley C
J Cataract Refract Surg; 2003 May; 29(5):941-8. PubMed ID: 12781280
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the 10-item vision core measure 1 (VCM1) scale (the Core Module of the Vision-Related Quality of Life scale) using Rasch analysis.
Lamoureux EL; Pesudovs K; Pallant JF; Rees G; Hassell JB; Caudle LE; Keeffe JE
Ophthalmic Epidemiol; 2008; 15(4):224-33. PubMed ID: 18780255
[TBL] [Abstract][Full Text] [Related]
28. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Rees G; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1001-6. PubMed ID: 17325138
[TBL] [Abstract][Full Text] [Related]
29. Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma?
Lamoureux EL; Ferraro JG; Pallant JF; Pesudovs K; Rees G; Keeffe JE
Optom Vis Sci; 2007 Aug; 84(8):789-96. PubMed ID: 17700342
[TBL] [Abstract][Full Text] [Related]
30. Psychological distress and visual functioning in relation to vision-related disability in older individuals with cataracts.
Walker JG; Anstey KJ; Lord SR
Br J Health Psychol; 2006 May; 11(Pt 2):303-17. PubMed ID: 16643701
[TBL] [Abstract][Full Text] [Related]
31. Impact of general health status on validity of visual impairment measurement.
Ahmadian L; Massof R
Ophthalmic Epidemiol; 2008; 15(5):345-55. PubMed ID: 18850472
[TBL] [Abstract][Full Text] [Related]
32. Establishing levels of indications for cataract surgery: combining clinical and questionnaire data into a measure of cataract impact.
McAlinden C; Jonsson M; Kugelberg M; Lundström M; Khadka J; Pesudovs K
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1095-101. PubMed ID: 22247472
[TBL] [Abstract][Full Text] [Related]
33. Application of stochastic measurement models to visual function rating scale questionnaires.
Massof RW
Ophthalmic Epidemiol; 2005 Apr; 12(2):103-24. PubMed ID: 16019693
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the impact of vision impairment.
Weih LM; Hassell JB; Keeffe J
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):927-35. PubMed ID: 11923230
[TBL] [Abstract][Full Text] [Related]
35. Can clinicians use the PHQ-9 to assess depression in people with vision loss?
Lamoureux EL; Tee HW; Pesudovs K; Pallant JF; Keeffe JE; Rees G
Optom Vis Sci; 2009 Feb; 86(2):139-45. PubMed ID: 19156007
[TBL] [Abstract][Full Text] [Related]
36. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
[TBL] [Abstract][Full Text] [Related]
37. Psychometric Properties of an Indian Translation of the Vision-related Activity Limitation Item Bank in Cataract.
Gothwal VK; Muthineni VV; Khadka J; Lamoureux EL; Pesudovs K;
Optom Vis Sci; 2019 Dec; 96(12):910-919. PubMed ID: 31834150
[TBL] [Abstract][Full Text] [Related]
38. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version.
Suzukamo Y; Oshika T; Yuzawa M; Tokuda Y; Tomidokoro A; Oki K; Mangione CM; Green J; Fukuhara S
Health Qual Life Outcomes; 2005 Oct; 3():65. PubMed ID: 16248900
[TBL] [Abstract][Full Text] [Related]
39. Validation of Catquest-9SF in Danish: developing a revised form of the Catquest-9SF - the Danish Catquest-7SF.
Nielsen E; Lundström M; Pesudovs K; Hjortdal J
Acta Ophthalmol; 2019 Mar; 97(2):173-177. PubMed ID: 30242976
[TBL] [Abstract][Full Text] [Related]
40. Measuring low vision service outcomes: Rasch analysis of the seven-item National Eye Institute Visual Function Questionnaire.
Ryan B; Court H; Margrain TH
Optom Vis Sci; 2008 Feb; 85(2):112-21. PubMed ID: 18296928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
